EDIL3 and breast neoplasm: EDIL-3 could activate EGF receptor (EGFR) signaling to promote bladder cell migration (Beckham et al., 2014), and lysyl oxidase secreted by hypoxic breast tumor cells was considered to be a crucial mediator of pre-metastatic niche formation (Erler et al., 2009).